NAPLEX Practice Exam 2026 – Comprehensive Test Preparation

Question: 1 / 1820

What is a major contraindication for the use of RANKL Inhibitor: Denosumab?

Hypertension

Hypocalcemia

A major contraindication for the use of RANKL inhibitor Denosumab is hypocalcemia. This is because Denosumab can decrease calcium levels in the blood, which can lead to serious complications such as hypocalcemia. Therefore, patients with a history of hypocalcemia should not take this medication. The other options, hypertension, diabetes and renal impairment, are not major contraindications for the use of RANKL inhibitor: Denosumab. While these conditions may require caution and monitoring, they do not completely prevent the use of the medication. It is important to consult with a healthcare provider before taking any medication and to discuss any pre-existing conditions that may affect its use.

Get further explanation with Examzify DeepDiveBeta

Diabetes

Renal impairment

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy